Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 09 tags : Positive save search
Context Therapeutics® Announces Positive Data from ONA-XR in Early Breast Cancer at 2021 San Antonio Breast Cancer Symposium
Published: 2021-12-09 (Crawled : 00:00) - globenewswire.com
CNTX | $1.36 -3.55% 29K
|
Health Technology
|
| O: 18.21%
H: 3.38%
C: -27.3%
therapeutics symposium positive cancer breast cancer ona-xr
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 30, 2021
Published: 2021-12-09 (Crawled : 23:00) - globenewswire.com
NDAQ | $60.99 -0.16% 830K
|
Finance
|
| O: 1.35%
H: 0.0%
C: 0.0%
positive nasdaq
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial
Published: 2021-12-09 (Crawled : 22:00) - biospace.com/
SRNE | $0.015 56K
|
Health Technology
|
| O: 1.03%
H: 2.75%
C: -2.6%
sp-102 trial therapeutics opioid positive results phase 3 topline
Ambrx Biopharma Inc. Presents Positive Data from Ongoing ACE-Breast-01 Phase 1 Clinical Study of ARX788 at San Antonio Breast Cancer Symposium
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: 16.04%
H: 9.95%
C: -3.87%
arx788 biopharma ongoing symposium phase 1 positive cancer breast cancer
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
AUPH | $5.035 -1.08% 510K
|
Health Technology
|
| O: 3.7%
H: 2.55%
C: -2.92%
treatment lupkynis topline results positive results topline lupus
COMMERCIAL METALS COMPANY PUBLISHES 2021 SUSTAINABILITY REPORT, DEMONSTRATING THE INDUSTRY LEADERSHIP POSITION OF OUR CARBON FOOTPRINT
Published: 2021-12-09 (Crawled : 19:00) - prnewswire.com
CMC | $53.77 -1.25% 200K
|
Non-Energy Minerals
|
| O: 3.6%
H: 0.0%
C: -3.68%
positive commercialization
ENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in Patients with HER2 Positive Metastatic Breast Cancer
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
AZN | News | $71.26 0.58% 3.8M
|
Health Technology
|
| O: 0.27%
H: 0.63%
C: -0.58%
enhertu positive cancer breast cancer her2- her2 metastatic breast cancer
YouTube Sensation Honoka Katayama Infuses Ukulele Music, Positivity and Hawaiian Spirit into Aloha Hoku – New Animated Preschool Series from Curiosity Ink Media
Published: 2021-12-09 (Crawled : 19:00) - globenewswire.com
GROM | $0.611 -1.45% 250K
|
Information
|
| O: -0.43%
H: 2.18%
C: -10.92%
media positive
BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression
Published: 2021-12-09 (Crawled : 17:00) - globenewswire.com
BETRF | $0.0745 550
|
Health Technology
|
| O: 2.53%
H: 3.7%
C: 0.05%
td-0148 preclinical positive depression pre-clinical
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy
Published: 2021-12-09 (Crawled : 17:00) - globenewswire.com
SRNE | $0.015 56K
|
Health Technology
|
| O: 1.03%
H: 2.75%
C: -2.6%
sp-102 trial therapeutics potential opioid positive therapy results phase 3 topline
Sustainability-Focused Executive Order Positions Federal Government for Advancement in Clean Energy Initiatives
Published: 2021-12-09 (Crawled : 17:00) - ameresco.com
AMRC M | $21.28 1.87% 170K
|
Industrial Services
|
| O: -0.41%
H: 1.36%
C: -2.93%
order energy positive
Sequans Introduces Low Power GNSS Positioning Technology on its Monarch 2 LTE-M/NB-IoT Platform
Published: 2021-12-09 (Crawled : 13:30) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 5.62%
H: 0.36%
C: -6.86%
SQNS | $0.52 1.92% 50K
|
Electronic Technology
|
| O: 0.51%
H: 4.69%
C: -3.06%
technology iot platform positive
Achilles Therapeutics Presents Positive Data at ESMO I-O Congress 2021 on High-Dose Manufacturing Process for Precision T Cell Therapies Targeting Clonal Neoantigens
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
ACHL | $0.781 -0.01% 62K
|
Manufacturing
|
| O: 5.43%
H: 6.09%
C: -5.15%
therapeutics positive t-cell
The Marketer's Guide to Segmentation, Targeting, & Positioning (STP Marketing)
Published: 2021-12-09 (Crawled : 12:00) - hubspot.com
HUBS M | $653.05 0.19% 130K
|
Technology Services
|
| O: 2.25%
H: 0.0%
C: 0.0%
positive market
Affimed to Host Virtual Investor Call Today to Discuss Treatment of CD30-positive Lymphoma Patients with Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13
Published: 2021-12-09 (Crawled : 12:00) - globenewswire.com
AFMD | $4.95 -7.48% 51K
|
Health Technology
|
| O: 4.4%
H: 0.44%
C: -9.16%
cd30 treatment blood positive oda
iOnctura Presents Positive Clinical Data At ESMO-IO Supporting Advancement of IOA-289, a Novel Autotaxin Inhibitor, Into Phase Ib Pancreatic Cancer Studies
Published: 2021-12-09 (Crawled : 08:00) - biospace.com/
PPRUF | News | $340.0 1.5K
|
Consumer Non-Durables
|
| O: -6.26%
H: 4.62%
C: 0.72%
PPRUY | News | $33.79 360K
|
Manufacturing
|
| O: -2.24%
H: 0.01%
C: -0.69%
ioa-289 xin positive cancer pancreatic
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.